Base editors
| CRISPR Medicine | This is an overview of articles on base editors
Sign-up to weekly Newsletter here.
Base editors
| CRISPR Medicine | This is an overview of articles on base editors
Sign-up to weekly Newsletter here.
IND Enabling
Phase I
Phase II
Phase III
Familial Hypercholesterolemia, HeFH, or Premature Coronary Artery Disease, CAD, (NCT06164730)
Sponsors:
Verve Therapeutics, Inc.![CMN+](https://d2qa4785ekzzy0.cloudfront.net/fileadmin/templates/crisprmedicine/images/CMN-plus-list.png)
Sponsors:
Verve Therapeutics, Inc.
![CMN+](https://d2qa4785ekzzy0.cloudfront.net/fileadmin/templates/crisprmedicine/images/CMN-plus-list.png)
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
T-Cell Acute Lymphoblastic Leukaemia, T-ALL, and Lymphoma, T-LL, (NCT05885464)
Sponsors:
Beam Therapeutics Inc.![CMN+](https://d2qa4785ekzzy0.cloudfront.net/fileadmin/templates/crisprmedicine/images/CMN-plus-list.png)
Sponsors:
Beam Therapeutics Inc.
![CMN+](https://d2qa4785ekzzy0.cloudfront.net/fileadmin/templates/crisprmedicine/images/CMN-plus-list.png)
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
T-cell Acute Lymphoblastic Leukaemia, T-ALL, (NCT05397184)
Sponsors:
Great Ormond Street Hospital for Children NHS Foundation Trust![CMN+](https://d2qa4785ekzzy0.cloudfront.net/fileadmin/templates/crisprmedicine/images/CMN-plus-list.png)
Sponsors:
Great Ormond Street Hospital for Children NHS Foundation Trust
![CMN+](https://d2qa4785ekzzy0.cloudfront.net/fileadmin/templates/crisprmedicine/images/CMN-plus-list.png)
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III